Carotid stenting

Find all the latest content on carotid stenting published on this website.

Preventing stroke due to narrowing of the carotid artery is a primary health concern and while surgery, such as carotid endarterectomy (CEA), has long been available, carotid artery stenting (CAS) offers a possible new and effective endovascular treatment. Keep up with the latest trials, imaging modalities, stents, devices and techniques, adjunctive pharmacotherapy, vascular access and bleeding here…

Filtered By
Carotid stenting

44 results

LIVE case: symptomatic RICA disease

From EUROPCR 2017

Consult this LIVE case on symptomatic RICA disease, that includes a LIVE demonstration from Maria Cecilia Hospital, GVM Care & Research - Cotignola, Italy.

A 73-year-old female with RICA disease:

Protection device usedDirect stentingUltra sound assessment
Fausto Castriota

Operator

Fausto Castriota
Antonio Micari

Operator

Antonio Micari

LIVE case: high risk LICA stenosis and unstable angina

From EUROPCR 2017

Consult this LIVE case on high risk LICA stenosis and unstable angina, that includes a LIVE demonstration from Maria Cecilia Hospital, GVM Care & Research - Cotignola, Italy.

A 73-year-old female with crescendo angina and critical LICA stenosis:

LCX PCI already doneCerebral Protection usedLICA intervention with double mesh stentIVUS assessment
Fausto Castriota

Operator

Fausto Castriota
Antonio Micari

Operator

Antonio Micari

PFO closure reduces recurrent strokes – a therapeutic promise is finally kept

22 May 2017

In patients with a patent foramen ovale (PFO) and cryptogenic stroke, percutaneous closure of the PFO has long been postulated to reduce the rate of recurrent strokes. However, up until now, trial data has failed to convincingly deliver a message of benefit for such an approach. Although the wait has been long, two recently reported trials finally seem to deliver on the therapeutic promise of PFO closure.

EuroPCR 2017 Highlights: Interventions for Stroke

20 May 2017 - From EUROPCR 2017

Interventional treatment of stroke is the future! M. Roffi and Ö. Göktekin along with L. N. Hopkins, neurosurgeon, explain how interventional cardiologists can respond to this challenge. Robust data supporting mechanical treatment of acute stroke increases daily. Until recently we believed intervention worked only within a 6 hour window, but now, the newly released DAWN trial shows that patient selection, IV r-tPA + clot retrieval can have a positive benefit for up to 24 hours after a stroke. An army of interventionalists is needed to treat the millions of eligible patients!

Symptomatic RICA disease

19 May 2017 – From EuroPCR 2017

Consult this session on symptomatic RICA disease, that includes a LIVE demonstration from Maria Cecilia Hospital, GVM Care & Research - Cotignola, Italy.

Clinical case

A 73-year-old female with RICA disease:
- Protection device used
- Direct stenting
- Ultra sound assessment

Trials for peripheral intervention and stroke prevention

18 May 2017 – From EuroPCR 2017

Management of multidistrict atherosclerotic patients and concomitant disease

18 May 2017 – From EuroPCR 2017

Consult this session on high risk LICA stenosis and unstable angina, that includes a LIVE demonstration from Maria Cecilia Hospital, GVM Care & Research - Cotignola, Italy.

Clinical case

A 73-year-old female with crescendo angina and critical LICA stenosis:
-    LCX PCI already done
-    Cerebral Protection used
-    LICA intervention with double mesh stent
-    IVUS assessment

Emerging strategies for carotid angioplasty

17 May 2017 – From EuroPCR 2017

Carotid stenting, present and future

What is the role of carotid artery stenting? Can it be considered today as a first choice in the treatment of critical bifurcation carotid stenosis? M. Roffi and A. Cremonesi explore the different dimensions of this procedure, its history, devices, operator experience, as well as existing limitations and challenges. What technological innovations hold promise and what do we expect from the future? Join us …

IFR-SWEDEHEART and DEFINE-FLAIR: iFR vs. FFR

Join W. Wijns as he explores issues surrounding the adoption of iFR or FFR as highlighted by two trials presented at ACC2017 – IFR-SWEDEHEART, from the well-known Swedish registry and DEFINE-FLAIR. Can the design of these trials shed light on the efficacy of either of these physiologic measurements? What important, and previously missing data, was finally reported? And the results of these trials – what impact will they have on the way you practice? Join us and find out…

This interview was recorded at the American College of Cardiology Scientific Sessions 2017 (ACC.17).